Adverse drug reactions associated with ivermectin use for COVID19 reported in the World Health Organization's pharmacovigilance database

被引：6
|
作者：
Campillo, Jeremy T. [1 ,2 ]
Faillie, Jean-Luc [1 ,3 ]
机构：
[1] CHU Montpellier, Dept Med Pharmacol & Toxicol, F-34000 Montpellier, France
[2] Univ Montpellier, Inst Rech Dev IRD, UMI 233 TransVIHMI, INSERM Unite 1175, Montpellier, France
[3] Univ Montpellier, IDESP UMR UA11, Inserm, F-34000 Montpellier, France
来源：
THERAPIE | 2022年 / 77卷 / 06期
关键词：
Ivermectin; Pharmacovigilance; COVID-19;
D O I：
10.1016/j.therap.2022.03.002
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：747 / 749
页数：4
相关论文
共 50 条
  • [1] Adverse drug reactions associated with ivermectin use for COVID-19 reported in the WHO's pharmacovigilance database
    Campillo, J.
    Faillie, J. L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 101 - 101
  • [2] Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance database
    Montastruc, Jean-Louis
    Lafaurie, Margaux
    de Canecaude, Claire
    Durrieu, Genevieve
    Sommet, Agnes
    Montastruc, Francois
    Bagheri, Haleh
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (11) : 4334 - 4340
  • [3] Myositis associated with Immune Checkpoint Inhibitors: A pharmacovigilance study using the World Health Organization's adverse drug reactions database
    Ladhari, C.
    Nguyen, T.
    Maria, A.
    Palassin, P.
    Quantin, X.
    Lesage, C.
    Taieb, G.
    Ayrignac, X.
    Rullier, P.
    Lambotte, O.
    Guilpain, P.
    Hillaire-Buys, D.
    Faillie, J. L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 103 - 103
  • [4] Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database
    Lee S. Nguyen
    Leslie T. Cooper
    Mathieu Kerneis
    Christian Funck-Brentano
    Johanne Silvain
    Nicolas Brechot
    Guillaume Hekimian
    Enrico Ammirati
    Badr Ben M’Barek
    Alban Redheuil
    Estelle Gandjbakhch
    Kevin Bihan
    Bénédicte Lebrun-Vignes
    Stephane Ederhy
    Charles Dolladille
    Javid J. Moslehi
    Joe-Elie Salem
    Nature Communications, 13
  • [5] Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database
    Nguyen, Lee S.
    Cooper, Leslie T.
    Kerneis, Mathieu
    Funck-Brentano, Christian
    Silvain, Johanne
    Brechot, Nicolas
    Hekimian, Guillaume
    Ammirati, Enrico
    Ben M'Barek, Badr
    Redheuil, Alban
    Gandjbakhch, Estelle
    Bihan, Kevin
    Lebrun-Vignes, Benedicte
    Ederhy, Stephane
    Dolladille, Charles
    Moslehi, Javid J.
    Salem, Joe-Elie
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [6] Data From the World Health Organization's Pharmacovigilance Database Supports the Prominent Role of Pneumonia in Mortality Associated With Clozapine Adverse Drug Reactions
    de Leon, Jose
    Sanz, Emilio J.
    De las Cuevas, Carlos
    SCHIZOPHRENIA BULLETIN, 2020, 46 (01) : 1 - 3
  • [7] Adverse drug reactions and ivermectin in COVID 19
    Montastruc, Jean-Louis
    THERAPIE, 2022, 77 (06): : 633 - 634
  • [8] Adverse drug reactions reported with antialdosterones to French Pharmacovigilance database
    Fedrizzi, S.
    Masson, R.
    Humbert, X.
    Gonzalez, C.
    Chenaf, C.
    Atzenhoffer, M.
    Sassier, M.
    Coquerel, A.
    Alexandre, J.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 47 - 47
  • [9] Ivermectin associated adverse events in the treatment and prevention of COVID-19 reported to the FACT pharmacovigilance project
    Farah, Rita
    Kazzi, Ziad
    Brent, Jeffrey
    Burkhart, Keith
    Wax, Paul
    Aldy, Kim
    CLINICAL TOXICOLOGY, 2022, 60 (08) : 942 - 946
  • [10] Fatal adverse drug reactions in children: A descriptive study in the World Health Organization pharmacovigilance database, 2010-2019
    Montastruc, Jean-Louis
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (01) : 201 - 208
12345